MTAP-DELETED SOLID TUMORS
Clinical trials for MTAP-DELETED SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new MTAP-DELETED SOLID TUMORS trials appear
Sign up with your email to follow new studies for MTAP-DELETED SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New targeted drug takes aim at Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug, BAY 3713372, for people with solid tumors that have a specific genetic deletion called MTAP. The drug is designed to kill cancer cells while sparing normal cells. The trial will first find a safe dose, then test how well it works in up to 450 particip…
Matched conditions: MTAP-DELETED SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Bayer • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New pill targets Hard-to-Treat cancers in early human trial
Disease control Recruiting nowThis early-phase study is testing a new oral drug called PEP08 in up to 40 adults with advanced or metastatic solid tumors that have lost a gene called MTAP. The drug works by blocking a protein that cancer cells need to grow. The main goals are to check safety, find the right do…
Matched conditions: MTAP-DELETED SOLID TUMORS
Phase: PHASE1 • Sponsor: PharmaEngine • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC